Companies: 10,795·Total market cap: $144.5T
Pro-Dex, Inc.

Pro-Dex, Inc.

PDEXNASDAQHealthcare● Active
$65.00
$-0.21(-0.32%)
Market Cap$207529400
P/E Ratio
52W High$68.99
52W Low$23.47

Pro-Dex, Inc. (PDEX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

PDEX · free cash flow · updated Jun 9, 2026

Core FCF metrics

Free cash flow was −$2.9M for FY2025 (fiscal year ending 2025-06-30), down 156.1% year-over-year The FCF margin was -4.4%.

FY2025 Free Cash Flow−$2.9M▼ -156.1% YoY
Trailing 12M (TTM)$7.1MTrailing 4Q sum · TTM positive vs latest FY negative
FCF Margin-4.4%−$2.9M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
pdex free cash flow history · pdex free cash flow chart · pdex free cash flow growth rate · pdex free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$2.9M▼ 156.1%-4.4%
FY2024$5.2M▲ +16.2%9.7%
FY2023$4.5M▲ +278.2%9.7%
FY2022−$2.5M▲ +0.0%-6.0%
FY2021−$2.5M▼ 147.2%-6.0%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
pdex free cash flow 2025 · pdex free cash flow 2024 · pdex free cash flow 2023 · pdex operating cash flow

FCF valuation metrics

Pro-Dex, Inc. (PDEX) trades at a FCF yield of 3.41% and a price-to-free-cash-flow ratio of 30.2x. FCF per share stands at $2.15, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
3.41%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$2.15
TTM FCF ÷ Shares Outstanding
Price / FCF
x30.2
Share Price ÷ FCF per Share
EV / FCF (TTM)
x30.8
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30
pdex price to free cash flow · pdex free cash flow yield · pdex free cash flow per share · pdex price to cash flow ratio

Cash flow statement summary

For FY2025, Pro-Dex, Inc. generated −$1.7M in operating cash flow and spent 1M in capital expenditures, yielding −$2.9M in free cash flow.

Operating Activities
−$1.7M
Cash from core business operations
2025-06-30
Investing Activities
−$0.2M
CapEx, acquisitions & investments
2025-06-30
Financing Activities
−$0.3M
Buybacks, dividends & debt
2025-06-30
FCF FormulaOperating CF (−$1.7M) − |CapEx| (1M) = FCF (−$2.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
pdex cash flow statement · pdex cash flow statement 2025 · pdex operating cash flow · pdex cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Pro-Dex, Inc.
Pro-Dex, Inc.YOU
PDEX
−$2.9M-156.1%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Pro-Dex, Inc. (PDEX) reported free cash flow of −$2.9M for FY2025 (fiscal year ending 2025-06-30), down 156.1% year-over-year. The FCF margin was -4.4%.

Based on available data, Pro-Dex, Inc. has maintained positive free cash flow for at least 8 fiscal year(s). FCF peaked at $5.3M in FY2020.

Pro-Dex, Inc.'s FCF yield is 3.41% and price-to-FCF ratio is 30.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

PDEX free cash flow · 8 questions

Pro-Dex, Inc. free cash flow was −$2.9M for FY2025, down 156.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $7.1M.

PDEX free cash flowPDEX FCFPDEX FCF 2025PDEX free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Pro-Dex, Inc. · Pro-Dex, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026